2018
DOI: 10.1088/2057-1976/aa99e9
|View full text |Cite
|
Sign up to set email alerts
|

An electroporation platform for Erlotinib resistance screening in living non-small cell lung cancer (NSCLC) cells

Abstract: An electroporation device was developed to introduce transient membrane pores and, consequently, enhance membrane permeability in living cells in a controllable manner. The validity of this platform was assessed on six non-small cell lung cancer (NSCLC) cell lines using different fluorescent dyes. Interestingly, it was found that the electroporation efficiency of these cells, i.e. the percentage of cells with membrane pores created, decreases significantly (from ∼60% to 30%) as their resistivity against Erloti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 34 publications
0
4
0
Order By: Relevance
“…Interestingly, Yan et al found that decreased EP efficiency of different nonsmall cell lung cancer cell lines was linked with higher resistance to erlotinib, a commonly used anticancer drug. 310 This behavior may be related to changes in membrane tension, which followed the same trend as EP efficiency. Vickers et al reported an inertial microfluidic device that trapped cells in EP chambers using microvortices for drug cocktail testing.…”
Section: Development Of Therapeuticsmentioning
confidence: 89%
See 1 more Smart Citation
“…Interestingly, Yan et al found that decreased EP efficiency of different nonsmall cell lung cancer cell lines was linked with higher resistance to erlotinib, a commonly used anticancer drug. 310 This behavior may be related to changes in membrane tension, which followed the same trend as EP efficiency. Vickers et al reported an inertial microfluidic device that trapped cells in EP chambers using microvortices for drug cocktail testing.…”
Section: Development Of Therapeuticsmentioning
confidence: 89%
“…The MCF-7 cells had a 20% lower cell viability compared to the MCF-7/ADR cells, whereas the EP-free, 24 h DOX treatment of MCF-7/ADR cells had a marginal effect on altering cell viability. Interestingly, Yan et al found that decreased EP efficiency of different nonsmall cell lung cancer cell lines was linked with higher resistance to erlotinib, a commonly used anticancer drug . This behavior may be related to changes in membrane tension, which followed the same trend as EP efficiency.…”
Section: Applicationsmentioning
confidence: 99%
“…Therefore, various micro-fabricated chips were designed to conduct electroporation at single-cell level without the use of high voltage. For example, based on a micro-electroporation system, a recent study has shown that the electroporation efficiency of lung tumor cells is closely related to their resistance against commonly used anti-cancer drugs [6,7], indicating the possibility of utilizing electroporation in the classification and prognosis of cancer.…”
Section: Electroporationmentioning
confidence: 99%
“…To investigate the response of different cancer cells, we designed a micro-electroporation system in our previous study [6,7]. We showed that the electroporation efficiency of lung tumor cells is closely related to their resistivity against Erlotinib (a commonly used drug for treating lung cancer).…”
Section: Electroporation Chipmentioning
confidence: 99%